In a recent hypothesis proposed by Brown and Heneka [93], LPS is suggested to contribute to AD pathophysiology through peripheral infections or GM dysbiosis, which elevate LPS concentrations in circulation and the brain, thereby promoting amyloid and tau pathologies along with microglial activation and subsequent neurodegeneration characteristic of AD. Here, MAPT is linked to Alzheimer disease.